Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Regional variation in surgical assessment of lymph nodes for staging among women with early-stage epithelial ovarian cancer.

Ulanday KT, Ward KK, Macera CA, Ji M, Plaxe SC.

Gynecol Oncol. 2014 Feb;132(2):411-5. doi: 10.1016/j.ygyno.2013.11.009. Epub 2013 Nov 15.

PMID:
24246773
2.

Risk factors for lymph node metastasis in apparent early-stage epithelial ovarian cancer: implications for surgical staging.

Powless CA, Aletti GD, Bakkum-Gamez JN, Cliby WA.

Gynecol Oncol. 2011 Sep;122(3):536-40. doi: 10.1016/j.ygyno.2011.05.001. Epub 2011 Jun 1.

PMID:
21636114
3.

Lymphadenectomy in surgical stage I epithelial ovarian cancer.

Svolgaard O, Lidegaard O, Nielsen ML, Nedergaard L, Mosgaard BJ, Lidang M, Mogensen O, Kock K, Blaakaer J, Staehr E, Andersen ES, Grove A, Høgdall C.

Acta Obstet Gynecol Scand. 2014 Mar;93(3):256-60. doi: 10.1111/aogs.12322. Epub 2014 Jan 22.

PMID:
24447203
4.

The potential therapeutic role of lymph node resection in epithelial ovarian cancer: a study of 13918 patients.

Chan JK, Urban R, Hu JM, Shin JY, Husain A, Teng NN, Berek JS, Osann K, Kapp DS.

Br J Cancer. 2007 Jun 18;96(12):1817-22. Epub 2007 May 22.

5.

Defining the optimal lymphadenectomy cut-off value in epithelial ovarian cancer staging surgery utilizing a mathematical model of validation.

Pereira A, Irishina N, Pérez-Medina T, Magrina JF, Magtibay PM, Kovaleva A, Rodríguez-Tapia A, Iglesias E.

Eur J Surg Oncol. 2013 Mar;39(3):290-6. doi: 10.1016/j.ejso.2012.12.006. Epub 2013 Jan 3.

PMID:
23290581
6.

Lymph node metastasis in grossly apparent clinical stage Ia epithelial ovarian cancer: Hacettepe experience and review of literature.

Desteli GA, Gultekin M, Usubutun A, Yuce K, Ayhan A.

World J Surg Oncol. 2010 Nov 30;8:106. doi: 10.1186/1477-7819-8-106.

7.

Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.

Kim HS, Park NH, Chung HH, Kim JW, Song YS, Kang SB.

Acta Obstet Gynecol Scand. 2008;87(11):1136-42. doi: 10.1080/00016340802478158.

PMID:
18951217
8.

Transdiaphragmatic cardiophrenic lymph node resection for Stage IV ovarian cancer.

LaFargue CJ, Bristow RE.

Gynecol Oncol. 2015 Sep;138(3):762-3. doi: 10.1016/j.ygyno.2015.06.002. Epub 2015 Jun 3. No abstract available.

PMID:
26049122
9.

The safety and feasibility of robotic-assisted lymph node staging in early-stage ovarian cancer.

Brown JV 3rd, Mendivil AA, Abaid LN, Rettenmaier MA, Micha JP, Wabe MA, Goldstein BH.

Int J Gynecol Cancer. 2014 Oct;24(8):1493-8. doi: 10.1097/IGC.0000000000000224.

PMID:
25078341
10.

Lymph node metastasis in patients with epithelial ovarian cancer macroscopically confined to the ovary: review of a single-institution experience.

Ulker V, Kuru O, Numanoglu C, Akbayır O, Polat I, Uhri M.

Arch Gynecol Obstet. 2014 May;289(5):1087-92. doi: 10.1007/s00404-013-3078-3. Epub 2013 Nov 9.

PMID:
24213097
11.

The investigation of the factors affecting retroperitoneal lymph node metastasis in stage IIIC and IV epithelial ovarian cancer.

Yavuzcan A, Baloglu A, Cetinkaya B.

Arch Gynecol Obstet. 2009 Dec;280(6):939-44. doi: 10.1007/s00404-009-1038-8. Epub 2009 Mar 21.

PMID:
19306011
12.

Lymph node sampling is of prognostic value in early stage epithelial ovarian carcinoma.

Skírnisdóttir I, Sorbe B.

Eur J Gynaecol Oncol. 2005;26(2):181-5.

PMID:
15857026
13.
14.

Prognostic factors for and prognostic value of mesenteric lymph node involvement in advanced-stage ovarian cancer.

Gouy S, Goetgheluck J, Uzan C, Duclos J, Duvillard P, Morice P.

Eur J Surg Oncol. 2012 Feb;38(2):170-5. doi: 10.1016/j.ejso.2011.10.006. Epub 2011 Nov 21.

PMID:
22104389
15.

Prognostic value of lymph node ratio in patients with advanced epithelial ovarian cancer.

Ataseven B, Grimm C, Harter P, Prader S, Traut A, Heitz F, du Bois A.

Gynecol Oncol. 2014 Dec;135(3):435-40. doi: 10.1016/j.ygyno.2014.10.003. Epub 2014 Oct 12.

PMID:
25312398
16.

Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.

Mahdi H, Moslemi-Kebria M, Levinson KL, Gojayev A, Lockhart D, Ali-Fehmi R, Munkarah AR.

Int J Gynecol Cancer. 2013 Sep;23(7):1226-30. doi: 10.1097/IGC.0b013e3182856736.

PMID:
23736258
17.

Prevalence of lymph node metastasis and prognostic significance of lymphadenectomy in apparent early-stage malignant ovarian sex cord-stromal tumors.

Nasioudis D, Kanninen TT, Holcomb K, Sisti G, Witkin SS.

Gynecol Oncol. 2017 May;145(2):243-247. doi: 10.1016/j.ygyno.2017.03.005. Epub 2017 Mar 11.

PMID:
28292524
18.

Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.

Negishi H, Takeda M, Fujimoto T, Todo Y, Ebina Y, Watari H, Yamamoto R, Minakami H, Sakuragi N.

Gynecol Oncol. 2004 Jul;94(1):161-6.

PMID:
15262135
19.

The prognostic impact of the ratio of positive lymph nodes on survival of epithelial ovarian cancer patients.

Mahdi H, Thrall M, Kumar S, Hanna R, Seward S, Lockhart D, Morris RT, Swensen R, Munkarah AR.

J Surg Oncol. 2011 Jun 1;103(7):724-9. doi: 10.1002/jso.21869. Epub 2011 Jan 16.

PMID:
21241015
20.

[Lymph node dissection in early ovarian cancer].

Ivanov S, Chakalova G, Hinev A, Kolev N, Ignatov V, Ivanov K.

Akush Ginekol (Sofiia). 2014;53(8):20-6. Review. Bulgarian.

PMID:
25672086

Supplemental Content

Support Center